India Capital Growth (IGC) Competitors GBX 188.50 +2.50 (+1.34%) As of 08:01 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock IGC vs. SLN, AMYT, BMY, OGN, GPH, AURA, ARTL, PHAR, KOD, and ORPHShould you be buying India Capital Growth stock or one of its competitors? The main competitors of India Capital Growth include Silence Therapeutics (SLN), Amryt Pharma (AMYT), Bloomsbury Publishing (BMY), Origin Enterprises (OGN), Global Ports (GPH), Aura Energy (AURA), Alpha Real Trust (ARTL), Pharos Energy (PHAR), Kodal Minerals (KOD), and Open Orphan (ORPH). These companies are all part of the "pharmaceutical products" industry. India Capital Growth vs. Its Competitors Silence Therapeutics Amryt Pharma Bloomsbury Publishing Origin Enterprises Global Ports Aura Energy Alpha Real Trust Pharos Energy Kodal Minerals Open Orphan Silence Therapeutics (LON:SLN) and India Capital Growth (LON:IGC) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability. Do institutionals & insiders have more ownership in SLN or IGC? 24.3% of India Capital Growth shares are owned by institutional investors. 0.2% of India Capital Growth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is SLN or IGC more profitable? India Capital Growth has a net margin of 93.35% compared to Silence Therapeutics' net margin of 0.00%. India Capital Growth's return on equity of 25.12% beat Silence Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Silence TherapeuticsN/A N/A N/A India Capital Growth 93.35%25.12%15.98% Which has better valuation & earnings, SLN or IGC? India Capital Growth has higher revenue and earnings than Silence Therapeutics. Silence Therapeutics is trading at a lower price-to-earnings ratio than India Capital Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSilence Therapeutics£11.35M0.00N/A-£48.60N/AIndia Capital Growth£46.21M3.52£43.14M£49.523.81 Does the media refer more to SLN or IGC? In the previous week, India Capital Growth had 1 more articles in the media than Silence Therapeutics. MarketBeat recorded 1 mentions for India Capital Growth and 0 mentions for Silence Therapeutics. Silence Therapeutics' average media sentiment score of 0.80 beat India Capital Growth's score of 0.76 indicating that Silence Therapeutics is being referred to more favorably in the media. Company Overall Sentiment Silence Therapeutics Positive India Capital Growth Positive SummaryIndia Capital Growth beats Silence Therapeutics on 9 of the 10 factors compared between the two stocks. Get India Capital Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for IGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IGC vs. The Competition Export to ExcelMetricIndia Capital GrowthAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£162.75M£1.28B£6.33B£3.00BDividend YieldN/A4.40%4.20%5.02%P/E Ratio3.8122.2113.99164.10Price / Sales3.522,345.981,723.95283,944.95Price / Cash97.3160.71128.4827.97Price / Book0.951.221.954.61Net Income£43.14M£263.65M£1.24B£5.90B7 Day Performance3.86%-0.10%0.13%2.11%1 Month Performance9.59%2.91%3.76%8.53%1 Year Performance3.86%5.53%18.24%64.39% India Capital Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IGCIndia Capital GrowthN/AGBX 188.50+1.3%N/A+1.3%£162.75M£46.21M3.8161SLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumeAMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownBMYBloomsbury Publishing3.2113 of 5 starsGBX 498+0.3%GBX 825+65.7%-27.2%£401.85M£382.40M10.6534,300News CoverageAnalyst ForecastOGNOrigin EnterprisesN/AGBX 3.75-0.1%N/AN/A£395.43M£183.08B10.8310,000Dividend IncreaseGPHGlobal PortsN/AN/AN/AN/A£231.21M£193.58M30,000.0020News CoverageAURAAura EnergyN/AGBX 7.10-5.3%N/A-13.2%£127.61MN/A-15,563.3550News CoverageARTLAlpha Real TrustN/AN/AN/AN/A£113.12M£8.46M96.445Gap UpHigh Trading VolumePHARPharos EnergyN/AGBX 21flatN/A-14.3%£104.76M£196.07M-2.23280Analyst ForecastKODKodal Minerals2.1255 of 5 starsGBX 0.36-0.3%GBX 1.23+241.2%-40.9%£72.40MN/A2,759.4290Gap DownORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71M-25.30179News Coverage Related Companies and Tools Related Companies Silence Therapeutics Competitors Amryt Pharma Competitors Bloomsbury Publishing Competitors Origin Enterprises Competitors Global Ports Competitors Aura Energy Competitors Alpha Real Trust Competitors Pharos Energy Competitors Kodal Minerals Competitors Open Orphan Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:IGC) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding India Capital Growth Please log in to your account or sign up in order to add this asset to your watchlist. Share India Capital Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
